Check out our most popular compounded medications! Get Started
The Temozolomide 420 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or capsules, including those in pediatric and geriatric groups. Temozolomide is an alkylating agent used in the treatment of certain types of brain cancers, such as glioblastoma multiforme and anaplastic astrocytoma, providing a therapeutic option for managing these challenging disease states.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Temozolomide 420 mg/5 mL Oral Liquid is a specially compounded medication designed for oral administration, providing a patient-friendly alternative to traditional capsule forms of the drug. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as those in pediatric or geriatric populations, or for those who may have an impaired gag reflex or dysphagia. The liquid form ensures that patients receive an accurate dose of the medication in a format that is easier to ingest.
Temozolomide is an alkylating agent used primarily in the treatment of certain brain cancers, including glioblastoma multiforme and anaplastic astrocytoma. It works by interfering with the development of cancer cells, ultimately causing cell death and slowing tumor growth. This medication is often part of a treatment regimen for patients who have been newly diagnosed or have recurrent cases of these cancers. The efficacy of temozolomide is due to its ability to cross the blood-brain barrier, reaching therapeutic concentrations within the central nervous system, which is crucial for the treatment of brain tumors.
The oral liquid formulation of temozolomide allows for flexible dosing, which is particularly important given the need for dose adjustments based on the patient's condition, response to therapy, and potential side effects. It is essential for prescribers to monitor patients closely for myelosuppression, a common side effect, as well as for signs of nausea and vomiting, which can be mitigated with antiemetic therapy. Prescribers should also be aware of the potential for temozolomide to interact with other medications and should adjust treatment plans accordingly.
Patients should be counseled on the importance of adhering to their dosing schedule and should be made aware of the potential side effects of temozolomide therapy. It is also important for patients to understand that this medication should be taken on an empty stomach to maximize its absorption and efficacy. As with any medication, patients should be encouraged to communicate any concerns or adverse effects they experience while taking temozolomide oral liquid.
At Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of our patients. Our team of knowledgeable compounding pharmacists is available to answer any questions and provide support to both patients and prescribers considering the use of Temozolomide 420 mg/5 mL Oral Liquid. For further information or to discuss specific patient needs, please reach out to us.
Temozolomide is an oral chemotherapy drug that is used primarily to treat certain types of brain tumors, such as glioblastoma multiforme or anaplastic astrocytoma. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. As with any medication, temozolomide can interact with other drugs, which may affect how it works or increase the risk of adverse effects. It is important for both patients and prescribers to be aware of these potential interactions to ensure the safe and appropriate use of temozolomide oral liquid.
One of the key interactions to be aware of is with drugs that affect the liver enzyme CYP3A4. Temozolomide is metabolized in the liver, and drugs that inhibit CYP3A4, such as ketoconazole, erythromycin, and grapefruit juice, can potentially increase the levels of temozolomide in the blood, leading to an increased risk of toxicity. Conversely, drugs that induce CYP3A4, such as rifampin and St. John's Wort, may decrease the effectiveness of temozolomide by increasing its metabolism.
Another important consideration is the use of temozolomide with bone marrow suppressants or other chemotherapy agents, as this can lead to additive bone marrow suppression. This means that the risk of anemia, leukopenia, and thrombocytopenia may be increased, and blood counts should be monitored closely. Vaccinations with live vaccines should be avoided during treatment with temozolomide due to the potential for reduced immune response and increased risk of infection.
Patients taking temozolomide should also be cautious with the use of non-prescription medications, supplements, and herbal products. For example, the concurrent use of NSAIDs, aspirin, or anticoagulants can increase the risk of bleeding, given the potential for decreased platelet counts with temozolomide therapy. Additionally, immunostimulants and immunosuppressants may have unpredictable effects on the immune system when used with temozolomide.
It is also important to note that temozolomide can cause nausea and vomiting, so it may interact with antiemetic medications. Adjustments to antiemetic regimens may be necessary to manage these side effects effectively. Furthermore, temozolomide's oral liquid formulation may contain excipients that could potentially interact with other medications, so it is important to review all components of the formulation when considering drug interactions.
Alcohol consumption should be limited or avoided while taking temozolomide, as it can exacerbate the medication's side effects, particularly its sedative and nausea-inducing effects. Additionally, temozolomide can cause dizziness or sleepiness, so patients should be cautious when taking other medications with similar sedative effects, including certain antihistamines, sleep medications, and prescription pain medications.
Due to the complexity and potential severity of drug interactions with temozolomide, it is crucial for patients to inform their healthcare providers of all medications, supplements, and herbal products they are currently taking. Healthcare providers should carefully review the patient's medication regimen to identify and manage any potential interactions. If you have any questions or concerns about the use of temozolomide oral liquid or its interactions with other drugs, please reach out to us at Bayview Pharmacy for further assistance.
The Temozolomide 420 mg/5 mL Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. Temozolomide, the active ingredient in this formulation, is an alkylating agent that works by interfering with the development of cancer cells, ultimately slowing or stopping their growth and spread in the body. This oral liquid formulation is particularly beneficial for patients who have difficulty swallowing pills, such as those with dysphagia, or for specific populations like children and the elderly who may require tailored dosing or have issues with solid dosage forms.
Upon oral administration, temozolomide is rapidly absorbed from the gastrointestinal tract. It undergoes chemical conversion at physiological pH to the active compound, MTIC (5-(3-methyltriazen-1-yl)imidazole-4-carboxamide). MTIC then exerts its cytotoxic effects by methylating DNA at the O6 and N7 positions of guanine, leading to DNA damage and triggering cell death in the rapidly dividing cancerous cells.
The compounding process ensures that the temozolomide is evenly distributed throughout the liquid, providing a uniform dose in each milliliter of the solution. The oral liquid form allows for flexible dosing, which can be adjusted according to the specific needs of the patient, based on factors such as body surface area or weight. This is especially important in pediatric and geriatric patients, where dosing requirements may vary significantly from the standard adult dose.
It is important for both patients and prescribers to understand that while the oral liquid formulation of temozolomide offers convenience and dosing flexibility, it should be handled with care, as with all chemotherapy drugs. Proper storage, handling, and administration are essential to ensure the safety and efficacy of the treatment. Additionally, patients should be monitored for potential side effects, and dosing may need to be adjusted based on the patient's response to therapy and any concurrent treatments.
For any questions regarding the Temozolomide 420 mg/5 mL Oral Liquid formulation, or to discuss the suitability of this medication for a specific patient, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure optimal patient care and treatment outcomes.
Temozolomide 420 mg/5 mL Oral Liquid is a chemotherapy medication used for the treatment of specific types of brain tumors, such as glioblastoma multiforme or anaplastic astrocytoma, in adult and pediatric patients who may have difficulties swallowing solid dosage forms.
The liquid formulation is taken orally with the use of an oral syringe or a dosing cup to ensure accurate measurement of the medication. It is important to follow the dosing instructions provided by your healthcare provider.
This form of Temozolomide is suitable for patients who have difficulty swallowing pills, including pediatric, geriatric, and adult patients with compromised swallowing ability due to medical conditions or the side effects of treatments.
The oral liquid form allows for more flexible dosing, is easier to swallow, and can be used by patients who cannot take solid forms of medication. It can be particularly beneficial for dose adjustments, as it can be more precisely measured than cutting pills.
It is important to store this medication in a cool, dry place, away from direct light and heat. Make sure the container is tightly closed when not in use. Always check the medication's label for specific storage instructions.
It is usually recommended to take Temozolomide on an empty stomach; however, you should consult with your healthcare provider for specific instructions. Some liquid medications can be mixed with food or beverages, but this might not be the case for all formulas.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double doses. Always consult with your healthcare provider for guidance specific to your treatment.
Yes, like all medications, Temozolomide can cause side effects. Common side effects include fatigue, nausea, vomiting, constipation, headache, and loss of appetite. More serious side effects may occur, and you should contact your healthcare provider if you experience unusual symptoms.
Yes, the dosage can be adjusted based on the patient’s needs, response to treatment, and as directed by a healthcare provider. The liquid form makes dose adjustments easier compared to solid forms.
Before starting treatment with Temozolomide Oral Liquid, discuss with your healthcare provider about your complete medical history, any allergies, current medications, and overall health condition. It is also important to follow their advice regarding blood monitoring and contraceptive use during treatment to prevent potential harm to a fetus.
The duration of treatment with Temozolomide Oral Liquid varies based on individual patient factors, the type and stage of the tumor, and how well the cancer responds to the medication. Your healthcare provider will determine the best treatment regimen for your situation.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
